InvestorsHub Logo
Followers 3
Posts 417
Boards Moderated 0
Alias Born 06/13/2007

Re: Matt Dillon post# 872

Friday, 02/13/2009 6:47:10 AM

Friday, February 13, 2009 6:47:10 AM

Post# of 18341
Has anyone seen this info.....

Diagnostic Testing & Technology Report

MacroArray Ready to Introduce Non-Invasive Prostate Cancer Test
April 2007
MacroArray Technologies (Philadelphia, PA) has developed a novel prostate cancer test that relies on the urine-based diagnostic marker known as PCADM-1 (for prostate cancer diagnostic marker 1), a 33 kDa chromosomal protein that is overexpressed in malignant prostate tissue. The marker was discovered by researchers at the Drexel University College of Medicine, with which MacroArray has a licensing agreement. Abbott Laboratories (Abbott Park, IL) will be the first to market the PCADM-1 urine test, after adapting the assay to its own platform.

Is this a confict of interest. Why has Abbott licensed this test also. Is this just another biomarker test to be used in conjunction with Hdvy's test. or a competing test. Just doing a late night word search on Abbott's endeavors and this came up. Any explainations appreciated in advance. Thanks